A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells

A novel coronavirus from patients with pneumonia in China, 2019

Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897

Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein

Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586

A novel coronavirus outbreak of global health concern

Wang, C., Horby, P. W., Hayden, F. G., & Gao, G. F. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30185-9 · Cited by 7,700

The EMBL-EBI search and sequence analysis tools APIs in 2019

Madeira, F., Park, Y. M., Lee, J., Buso, N., Gur, T., Madhusoodanan, N., Basutkar, P., Tivey, A. R. N., Potter, S. C., Finn, R. D., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz268 · Cited by 4,167

Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins

Lam, T. T., Jia, N., Zhang, Y.-W., Shum, M. H.-H., Jiang, J.-F., Zhu, H., Tong, Y., Shi, Y., Ni, X.-B., Liao, Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2169-0 · Cited by 1,877

Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor

Ge, X.-Y., Li, J.-L., Yang, X.-L., Chmura, A. A., Zhu, G., Epstein, J. H., Mazet, J. K., Hu, B., Zhang, W., Peng, C., et al. (2013) · Nature · doi:10.1038/nature12711 · Cited by 1,778

YASARA View—molecular graphics for all devices—from smartphones to workstations

Krieger, E., & Vriend, G. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu426 · Cited by 1,573

Interaction of SARS-CoV-2 with host cells and antibodies: experiment and simulation

Nguyen, H. V., Nguyen, H. L., Lan, P. D., Thai, N. Q., Sikora, M., & Li, M. S. (2023) · Chemical Society Reviews · doi:10.1039/d1cs01170g · Cited by 15

COVID-19: the CaMKII-like system of S protein drives membrane fusion and induces syncytial multinucleated giant cells

Liu, W., & hualan, L. (2021) · Immunologic Research · doi:10.1007/s12026-021-09224-1 · Cited by 14

An unexpected biomaterial against SARS-CoV-2: Bio-polyphosphate blocks binding of the viral spike to the cell receptor

Müller, W. E. G., Schröder, H. C., Neufurth, M., & Wang, X. (2021) · Materials Today · doi:10.1016/j.mattod.2021.07.029 · Cited by 15

Peptides and peptidomimetics as therapeutic agents for Covid‐19

Dahal, A., Sonju, J. J., Kousoulas, K. G., & Jois, S. D. S. (2021) · Peptide Science · doi:10.1002/pep2.24245 · Cited by 14

SARS-CoV-2 cell-to-cell spread occurs rapidly and is insensitive to antibody neutralizationPreprint

Jackson, L., Rodel, H. E., Hwa, S.-H., Cele, S., Ganga, Y., Tegally, H., Bernstein, M. P., Giandhari, J., COMMIT-KZN Team, Gosnell, B. I., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.01.446516 · Cited by 16

Can Polyphenols be Used as Anti-Inflammatory Agents against Covid-19 (SARS-CoV-2)-Induced Inflammation?

Gelen, V., Kükürt, A., Şengül, E., Başer, Ö. F., & Karapehlivan, M. (2021) · Biochemistry · doi:10.5772/intechopen.98684 · Cited by 13

Genomic determinants of Furin cleavage in diverse European SARS-related bat coronaviruses

Sander, A., Moreira‐Soto, A., Yordanov, S., Toplak, I., Balboni, A., Ameneiros, R. S., Corman, V. M., Drosten, C., & Drexler, J. F. (2022) · Communications Biology · doi:10.1038/s42003-022-03421-w · Cited by 13

Exocyst complex component 2 is a potential host factor for SARS-CoV-2 infection

Yi, R., Hashimoto, R., Sakamoto, A., Matsumura, Y., Nagao, M., Takahashi, K., & Takayama, K. (2022) · iScience · doi:10.1016/j.isci.2022.105427 · Cited by 13

A REVIEW OF ARTIFICIAL INTELLIGENCE IN TREATMENT OF COVID-19

Gandla, K., Teja, K., Babu, P. V., Sagapola, R., & Sudhakar, P. (2022) · Journal of Pharmaceutical Negative Results · doi:10.47750/pnr.2022.13.s01.31 · Cited by 16

SARS-CoV-2 infection of airway organoids reveals conserved use of Tetraspanin-8 by Ancestral, Delta, and Omicron variants

Hysenaj, L., Little, S., Kulhanek, K. R., Magnen, M., Bahl, K., Gbenedio, O. M., Prinz, M., Rodriguez, L., Andersen, C., Rao, A. A., et al. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.01.011 · Cited by 13

Aprotinin—Drug against Respiratory Diseases

Ivachtchenko, A. V., Ivashchenko, A. A., Shkil, D. O., & Ivashchenko, I. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311173 · Cited by 13

Comparative Review of the State of the Art in Research on the Porcine Epidemic Diarrhea Virus and SARS-CoV-2, Scope of Knowledge between Coronaviruses

Rosas-Murrieta, N. H., Rodríguez-Enríquez, A., Camacho, I. H., Millán-Pérez-Peña, L., Santos‐López, G., & Rivera-Benítez, J. F. (2024) · Viruses · doi:10.3390/v16020238 · Cited by 13

A dual inhibitor of PIP5K1C and PIKfyve prevents SARS-CoV-2 entry into cells

Seo, Y., Jang, Y., Lee, S., Rhlee, J. H., Kong, S., Vo, T. T. H., Kim, M. H., Lee, M. K., Kim, B., Hong, S. Y., et al. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01283-2 · Cited by 13

Assessing the consequences of environmental exposures on the expression of the human receptor and proteases involved in SARS-CoV-2 cell-entry

Watzky, M., de Dieuleveult, M., Letessier, A., Saint‐Ruf, C., & Miotto, B. (2020) · Environmental Research · doi:10.1016/j.envres.2020.110317 · Cited by 13

An Overview of Spike Surface Glycoprotein in Severe Acute Respiratory Syndrome–Coronavirus

Kathiravan, M. K., Radhakrishnan, S., Namasivayam, V., & Senthilkumar, P. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.637550 · Cited by 13

Epigenetic Mechanisms Underlying COVID-19 Pathogenesis

Kaneko, S., Takasawa, K., Asada, K., Shinkai, N., Bolatkan, A., Yamada, M., Takahashi, S., Machino, H., Kobayashi, K., Komatsu, M., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9091142 · Cited by 13

Enzyme inhibition as a potential therapeutic strategy to treat COVID-19 infection

Paulsson-Habegger, L., Snabaitis, A. K., & Wren, S. P. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116389 · Cited by 13

Spike Protein of SARS‐CoV‐2 Activates Macrophages and Contributes to Induction of Acute Lung Inflammations in Mice

Cao, X., Tian, Y., Nguyen, V., Zhang, Y., Gao, C., Yin, R. L., Carver, W., Fan, D., Albrecht, H., Cui, T., et al. (2021) · The FASEB Journal · doi:10.1096/fasebj.2021.35.s1.00265 · Cited by 13

Alpha-Soluble NSF Attachment Protein Prevents the Cleavage of the SARS-CoV-2 Spike Protein by Functioning as an Interferon-Upregulated Furin Inhibitor

Wang, J., Luo, J. D., Wen, Z., Wang, X., Shuai, L., Zhong, G., Wang, C., Sun, Z., Chen, W., Ge, J., et al. (2022) · mBio · doi:10.1128/mbio.02443-21 · Cited by 13

Looking for SARS-CoV-2 Therapeutics Through Computational Approaches

Vincenzi, M., Mercurio, F. A., & Leone, M. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666221004104430 · Cited by 13

Drugs for the prevention and treatment of COVID-19 and its complications: An update on what we learned in the past 2 years

Remuzzi, G., Schiaffino, S., Santoro, M. G., FitzGerald, G. A., Melino, G., & Patrono, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.987816 · Cited by 16

Identification of phytochemicals in Qingfei Paidu decoction for the treatment of coronavirus disease 2019 by targeting the virus-host interactome

Li, Y., Wu, Y., Li, S., Li, Y., Zhang, X., Shou, Z., Gu, S., Zhou, C., Xu, D., Zhao, K., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113946 · Cited by 13

Oligomerization-Dependent Beta-Structure Formation in SARS-CoV-2 Envelope Protein

Surya, W., & Torres, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113285 · Cited by 13

Human antibody recognition and neutralization mode on the NTD and RBD domains of SARS-CoV-2 spike protein

Otsubo, R., Minamitani, T., Kobiyama, K., Fujita, J., Ito, T., Ueno, S., Anzai, I., Tanino, H., Aoyama, H., Matsuura, Y., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-24730-4 · Cited by 13

Factor Xa cleaves SARS-CoV-2 spike protein to block viral entry and infection

Dong, W., Wang, J., Tian, L., Zhang, J., Settles, E. W., Qin, C., Kollath, D. R., Itogawa, A. N., Celona, K. R., Yi, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37336-9 · Cited by 13

Weapons and Strategies against COVID-19: A Perspective

Mishra, R., Chaudhary, K., & Mishra, I. (2023) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201024666230525161432 · Cited by 13

Exposure of human intestinal epithelial cells and primary human hepatocytes to trypsin-like serine protease inhibitors with potential antiviral effect

Pászti-Gere, E., Pomothy, J. M., Jerzsele, Á., Pilgram, O., & Steinmetzer, T. (2021) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2021.1886093 · Cited by 13

Crystal structure of inhibitor-bound human MSPL that can activate high pathogenic avian influenza

Ohno, A., Maita, N., Tabata, T., Nagano, H., Arita, K., Ariyoshi, M., Uchida, T., Nakao, R., Ulla, A., Sugiura, K., et al. (2021) · Life Science Alliance · doi:10.26508/lsa.202000849 · Cited by 13

Predominance of the SARS-CoV-2 Lineage P.1 and Its Sublineage P.1.2 in Patients from the Metropolitan Region of Porto Alegre, Southern Brazil in March 2021

Franceschi, V. B., Caldana, G. D., Perin, C., Horn, A., Peter, C., Cybis, G. B., Ferrareze, P. A. G., Rotta, L. N., Cadegiani, F., Zimerman, R. A., et al. (2021) · Pathogens · doi:10.3390/pathogens10080988 · Cited by 14

Prediction of SARS-CoV-2 Omicron Variant Immunogenicity, Immune Escape and Pathogenicity, through the Analysis of Spike Protein-Specific Core Unique Peptides

Pierros, V., Kontopodis, E., Stravopodis, D. J., & Tsangaris, G. T. (2022) · Vaccines · doi:10.3390/vaccines10030357 · Cited by 13

Identification of Atovaquone, Ouabain and Mebendazole as FDA Approved Drugs Tar-geting SARS-CoV-2 (Version 4)Preprint

Farag, A., Wang, P., Boys, I. N., Eitson, J. L., Ohlson, M. B., Fan, W., McDougal, M. B., Ahmed, M., Schoggins, J. W., & Sadek, H. A. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12003930.v4 · Cited by 13

Exosomes in COVID‐19 infection: Focus on role in diagnosis, pathogenesis, immunity, and clinical trials

Aljuhani, A., Albalawi, O., Albalawi, R., Alsalama, R., Alatawi, S., Altemani, R., Abdel‐Maksoud, M. S., & Elsherbiny, N. (2023) · Cell Biology International · doi:10.1002/cbin.12014 · Cited by 12

Toward Understanding Molecular Bases for Biological Diversification of Human Coronaviruses: Present Status and Future Perspectives

Koma, T., Adachi, S., Doi, N., Adachi, A., & Nomaguchi, M. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.02016 · Cited by 13

Characterization of the SARS-CoV-2 Host Response in Primary Human Airway Epithelial Cells from Aged Individuals

Bharathiraja, S., Larabee, J. L., Bodas, M., Moore, A. R., Burgett, A. W. G., Myers, D. A., Georgescu, C., Wren, J. D., Papin, J. F., & Walters, M. S. (2021) · Viruses · doi:10.3390/v13081603 · Cited by 12

Murine alveolar macrophages rapidly accumulate intranasally administered SARS-CoV-2 Spike protein leading to neutrophil recruitment and damage

Park, C., Hwang, I., Yan, S. L.-S., Vimonpatranon, S., Wei, D., Ryk, D. V., Girard, A., Cicala, C., Arthos, J. A., & Kehrl, J. H. (2023) · eLife · doi:10.7554/elife.86764 · Cited by 12

Utilizing nanozymes for combating COVID-19: advancements in diagnostics, treatments, and preventative measures

Wang, J., Xie, Q., Song, H., Chen, X., Zhang, X., Zhao, X., Hao, Y., Zhang, Y., Li, H., Li, N., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01945-9 · Cited by 14

Dissecting the intricacies of human antibody responses to SARS-CoV-1 and SARS-CoV-2 infection

Wang, R., Han, Y., Zhang, R., Zhu, J., Nan, X., Liu, Y., Yang, Z., Zhou, B., Yu, J., Lin, Z., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.10.007 · Cited by 13

High-throughput screening of genetic and cellular drivers of syncytium formation induced by the spike protein of SARS-CoV-2

Chan, C. W. F., Wang, B., Nan, L., Huang, X., Mao, T., Chu, H. Y., Luo, C., Shum, H. C., Choi, G. C. G., Shum, H. C., et al. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01140-z · Cited by 14

Infection kinetics, syncytia formation, and inflammatory biomarkers as predictive indicators for the pathogenicity of SARS-CoV-2 Variants of Concern in Calu-3 cells

Purwono, P. B., Vacharathit, V., Manopwisedjaroen, S., Ludowyke, N., Suksatu, A., & Thitithanyanont, A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0301330 · Cited by 12

Cell type-specific adaptation of the SARS-CoV-2 spike

Carrascosa-Sàez, M., Marqués, M.-C., IBV-Covid19-Pipeline, T., Geller, R., Elena, S. F., Rahmeh, A., Dufloo, J., & Sanjuán, R. (2024) · Virus Evolution · doi:10.1093/ve/veae032 · Cited by 13

Structural insights into Furin enzyme inhibition to block SARS-CoV-2 spike protein cleavage: an in-silico approach

Ramakrishnan, J., & Kumaradhas, P. (2024) · 3 Biotech · doi:10.1007/s13205-024-04054-y · Cited by 12

SARS-CoV-2 Omicron subvariants progressively adapt to human cells with altered host cell entry

Sakurai, Y., Okada, S., Ozeki, T., Yoshikawa, R., Kinoshita, T., & Yasuda, J. (2024) · mSphere · doi:10.1128/msphere.00338-24 · Cited by 12

Inhibiting fusion with cellular membrane system: therapeutic options to prevent severe acute respiratory syndrome coronavirus-2 infection

Mitra, P. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00260.2020 · Cited by 12

Transmissibility and pathogenicity of SARS-CoV-2 variants in animal models

Kim, Y., Casel, M. A. B., & Choi, Y. K. (2022) · The Journal of Microbiology · doi:10.1007/s12275-022-2033-z · Cited by 14

Immunouniverse of SARS-CoV-2

Jiménez, D., & Arias, M. T. (2022) · Immunological Medicine · doi:10.1080/25785826.2022.2066251 · Cited by 12

Recent trends in next generation immunoinformatics harnessed for universal coronavirus vaccine design

Lim, C. P., Kok, B. H., Lim, H. T., Chuah, C., Abdul‐Rahman, B., Majeed, A. B. A., Wykes, M., Leow, C. Y., & Leow, C. Y. (2022) · Pathogens and Global Health · doi:10.1080/20477724.2022.2072456 · Cited by 12

In Vitro Evidence of Statins’ Protective Role against COVID-19 Hallmarks

Fiore, D., Proto, M., Franceschelli, S., Pascale, M. C., Bifulco, M., & Gazzerro, P. (2022) · Biomedicines · doi:10.3390/biomedicines10092123 · Cited by 12

Autophagy in severe acute respiratory syndrome coronavirus 2 infection

Chen, D., & Zhang, H. (2022) · Current Opinion in Physiology · doi:10.1016/j.cophys.2022.100596 · Cited by 12

SARS-CoV-2 Spike Protein Mutation at Cysteine-488 Impairs Its Golgi Localization and Intracellular S1/S2 Processing

Yamamoto, Y., Inoue, T., Inoue, M., Murae, M., Fukasawa, M., Kaneko, M. K., Kato, Y., & Noguchi, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415834 · Cited by 12

Folic Acid and Leucovorin Have Potential to Prevent SARS-CoV-2-Virus Internalization by Interacting with S-Glycoprotein/Neuropilin-1 Receptor Complex

Škrbić, R., Travar, M., Stojiljković, M. P., Djuric, D. M., & Suručić, R. V. (2023) · Molecules · doi:10.3390/molecules28052294 · Cited by 14

Restriction of Viral Glycoprotein Maturation by Cellular Protease Inhibitors

Lotke, R., Petersen, M., & Sauter, D. (2024) · Viruses · doi:10.3390/v16030332 · Cited by 13

Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19?

Morris, G., Athan, E., Walder, K. R., Bortolasci, C. C., O'Neil, A. E., Marx, W., Berk, M., Carvalho, A. F., Maes, M. H. J., & Puri, B. K. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118541 · Cited by 12

Mechanisms of Infection By SARS-CoV-2, Inflammation and Potential Links With the Microbiome

Aguirre‐García, M. M., Mancilla-Galindo, J., Paredes‐Paredes, M., Tiburcio, Á. Z., & Ávila‐Vanzzini, N. (2021) · Future Virology · doi:10.2217/fvl-2020-0310 · Cited by 12

Enhanced sampling protocol to elucidate fusion peptide opening of SARS-CoV-2 spike protein

Remington, J. M., McKay, K. T., Ferrell, J. B., Schneebeli, S. T., & Li, J. (2021) · Biophysical Journal · doi:10.1016/j.bpj.2021.05.022 · Cited by 13

Review: Development of SARS-CoV-2 immuno-enhanced COVID-19 vaccines with nano-platform

Sa-nguanmoo, N., Namdee, K., Khongkow, M., Ruktanonchai, U., Zhao, Y., & Liang, X. (2021) · Nano Research · doi:10.1007/s12274-021-3832-y · Cited by 12

A Structurally Conserved RNA Element within SARS-CoV-2 ORF1a RNA and S mRNA Regulates Translation in Response to Viral S Protein-Induced Signaling in Human Lung Cells

Basu, A., Penumutchu, S. R., Nguyen, K., Mbonye, U. R., Tolbert, B. S., Karn, J., Komar, A. A., & Mazumder, B. (2021) · Journal of Virology · doi:10.1128/jvi.01678-21 · Cited by 12

Comparison of SARS-CoV-2 Evolution in Paediatric Primary Airway Epithelial Cell Cultures Compared with Vero-Derived Cell Lines

Bamford, C., Broadbent, L., Aranday-Cortés, E., McCabe, M., McKenna, J. P., Courtney, D., Touzelet, O., Ali, A., Roberts, G. C., López–Campos, G., et al. (2022) · Viruses · doi:10.3390/v14020325 · Cited by 12

ORFeome Phage Display Reveals a Major Immunogenic Epitope on the S2 Subdomain of SARS-CoV-2 Spike Protein

Ballmann, R., Hotop, S., Bertoglio, F., Steinke, S., Heine, P. A., Chaudhry, M. Z., Jahn, D., Pucker, B., Baldanti, F., Piralla, A., et al. (2022) · Viruses · doi:10.3390/v14061326 · Cited by 12

SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise

Duerr, R., Crosse, K. M., Valero-Jimenez, A. M., & Dittmann, M. (2021) · Microorganisms · doi:10.3390/microorganisms9071389 · Cited by 12

Effect of statins on SARS-CoV-2 infectionPreprint

Moeller, R. A., Belinchón, F. J. Z., Laßwitz, L., Kirui, J., Brogden, G., Gunesch, A. P., Pietschmann, T., Wichmann, D., Kluge, S., & Gerold, G. (2020) · medRxiv · doi:10.1101/2020.07.13.20152272 · Cited by 12

Progress report on the coronavirus pandemic

(2020) · Nature · doi:10.1038/d41586-020-02414-1 · Cited by 12

Potential Effects of Hyperglycemia on SARS-CoV-2 Entry Mechanisms in Pancreatic Beta Cells

Michaels, T. M., Essop, M. F., & Joseph, D. E. (2024) · Viruses · doi:10.3390/v16081243 · Cited by 12

SARS-CoV-2 spike-induced syncytia are senescent and contribute to exacerbated heart failure

Li, H., Wan, L., Liu, M., Ma, E., Huang, L., Yang, Y., Li, Q., Fang, Y., Li, J., Han, B., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012291 · Cited by 11

Conformational dynamics of SARS-CoV-2 Omicron spike trimers during fusion activation at single molecule resolution

Dey, S., Pahari, P., Mukherjee, S., Munro, J. B., & Das, D. K. (2024) · Structure · doi:10.1016/j.str.2024.09.008 · Cited by 11

A human monoclonal antibody neutralizing SARS-CoV-2 Omicron variants containing the L452R mutation

Stein, S. C., Hansen, G., Ssebyatika, G. L., Stroh, L. J., Ochulor, O., Herold, E., Schwarzloh, B., Mutschall, D., Zischke, J., Cordes, A. K., et al. (2024) · Journal of Virology · doi:10.1128/jvi.01223-24 · Cited by 12

Detection of SARS-CoV-2 RNA in nasopharyngeal swabs from COVID-19 patients and asymptomatic cases of infection by real-time and digital PCR

Ternovoi, V. A., Lutkovskiy, R. Y., Пономарева, Е. П., Gladysheva, A. V., Владимировна, Ч. Е., Леонидовна, Т. Н., Smirnova, A. M., Nazarenko, A. A., Loktev, V. B., Gavrilova, E. V., et al. (2020) · Russian Clinical Laboratory Diagnostics · doi:10.18821/0869-2084-2020-65-12-785-792 · Cited by 11

Adjusting extracellular pH to prevent entry of SARS-CoV-2 into human cells

Wang, B. (2021) · Genome · doi:10.1139/gen-2020-0167 · Cited by 11

“Silent Hypoxemia” Leads to Vicious Cycle of Infection, Coagulopathy and Cytokine Storm in COVID-19: Can Prophylactic Oxygen Therapy Prevent It?

Chauhan, A., Kaur, R., Chakrbarti, P., & Pal, A. (2021) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-021-00967-0 · Cited by 11

From the environment to the cells: An overview on pivotal factors which affect spreading and infection in COVID-19 pandemic

Zarei, M., Rahimi, K., Hassanzadeh, K., Abdi, M., Hosseini, V., Fathi, A., & Kakaei, K. (2021) · Environmental Research · doi:10.1016/j.envres.2021.111555 · Cited by 11

Biology and Pathogenesis of SARS-CoV-2: Understandings for Therapeutic Developments against COVID-19

Sharma, H. N., Latimore, C. O. D., & Matthews, Q. L. (2021) · Pathogens · doi:10.3390/pathogens10091218 · Cited by 12

National Academy of Medicine of Korea (NAMOK) Key Statements on COVID-19

Shin, H., Park, H., Kwon, J. S., Namgoong, H., Kim, S., Kim, J. M., Peck, K. R., Lee, K., Lee, J., Lee, J., et al. (2021) · Journal of Korean Medical Science · doi:10.3346/jkms.2021.36.e287 · Cited by 11

An evolutionary insight into Severe Acute Respiratory Syndrome Coronavirus 2 Omicron variant of concern.

Paz, M., Aldunate, F., Arce, R., Ferreiro, I., & Cristina, J. (2022) · Virus Research · doi:10.1016/j.virusres.2022.198753 · Cited by 11

Hyper-Variable Spike Protein of Omicron Corona Virus and Its Differences with Alpha and Delta Variants: Prospects of RT-PCR and New Vaccine

Chakraborty, A. K. (2022) · Journal of Emerging Diseases and Virology · doi:10.16966/2473-1846.166 · Cited by 12

Metalloprotease-Dependent S2′-Activation Promotes Cell–Cell Fusion and Syncytiation of SARS-CoV-2

Harte, J. V., Wakerlin, S. L., Lindsay, A. J., McCarthy, J. V., & Coleman-Vaughan, C. (2022) · Viruses · doi:10.3390/v14102094 · Cited by 11

Repurposing of Chemotherapeutics to Combat COVID-19

Nandi, S., Nayak, B. S., Khede, M. K., & Saxena, A. K. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666221130142517 · Cited by 11

Peptide-based inhibitors hold great promise as the broad-spectrum agents against coronavirus

Tang, M., Zhang, X., Huang, Y., Cheng, W., Qu, J. T., Gui, S., Liang, L., & Li, S. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1093646 · Cited by 11

Severe COVID-19versusmultisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection

Fraser, R., Resendiz, A. O., Dockrell, D. H., Müller-Trutwin, M. C., & Mazein, A. (2023) · European Respiratory Review · doi:10.1183/16000617.0197-2022 · Cited by 11

Two Resveratrol Oligomers Inhibit Cathepsin L Activity to Suppress SARS-CoV-2 Entry

Wang, C., Ye, X., Ding, C., Zhou, M., Li, W., Wang, Y., You, Q., Zong, S., Peng, Q., Duanmu, D., et al. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c07811 · Cited by 11

In silico study unfolds inhibitory potential of epicatechin gallate against SARS-CoV-2 entry and replication within the host cell

Rajak, P., & Ganguly, A. (2023) · Mechanobiology in Medicine · doi:10.1016/j.mbm.2023.100015 · Cited by 11

Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vector

Liang, Z., Wu, X., Wu, J., Liu, S., Tong, J., Li, T., Yu, Y., Zhang, L., Zhao, C., Lu, Q., et al. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2261566 · Cited by 11

Cell type dependent stability and virulence of a recombinant SARS-CoV-2, and engineering of a propagation deficient RNA replicon to analyze virus RNA synthesis

Wang, L., Guzman, M., Muñoz‐Santos, D., Honrubia, J. M., Ripoll-Gómez, J., Delgado, R. B., Sola, I., Enjuanes, L., & Zúñiga, S. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1268227 · Cited by 11

SARS-CoV-2: A Glance at the Innate Immune Response Elicited by Infection and Vaccination

Manfrini, N., Notarbartolo, S., Grifantini, R., & Pesce, E. (2024) · Antibodies · doi:10.3390/antib13010013 · Cited by 13

Durable cross-protective neutralizing antibody responses elicited by lipid nanoparticle-formulated SARS-CoV-2 mRNA vaccines

Bae, K. H., Shunmuganathan, B. D. O., Zhang, L., Lim, A., Gupta, R., Wang, Y.-M., Chua, B. L., Wang, Y., Gu, Y., Qian, X., et al. (2024) · npj Vaccines · doi:10.1038/s41541-024-00835-x · Cited by 11

Early detection of emerging viral variants through analysis of community structure of coordinated substitution networks

Mohebbi, F., Zelikovsky, A., Mangul, S., Chowell, G., & Skums, P. (2024) · Nature Communications · doi:10.1038/s41467-024-47304-6 · Cited by 11

Targeting furin, a cellular proprotein convertase, for COVID-19 prevention and therapeutics

Jiang, X., Li, D., Maghsoudloo, M., Zhang, X., Ma, W., & Fu, J. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104026 · Cited by 11

Therapeutic approaches against coronaviruses acute respiratory syndrome

Servidio, C., & Stellacci, F. (2020) · Pharmacology Research & Perspectives · doi:10.1002/prp2.691 · Cited by 11

Elevation in viral entry genes and innate immunity compromise underlying increased infectivity and severity of COVID-19 in cancer patients

Kwan, J. Y. Y., Lin, L., Bell, R., Bruce, J. P., Richardson, C., Pugh, T. J., & Liu, F. (2021) · Scientific Reports · doi:10.1038/s41598-021-83366-y · Cited by 11

Screening strategy of TMPRSS2 inhibitors by FRET-based enzymatic activity for TMPRSS2-based cancer and COVID-19 treatment.

Chen, Y., Huang, W., Yang, C., Cheng, F., Chiu, Y., Chen, H., Huynh, T. K., Huang, C., Chen, C., Wang, H., et al. (2021) · PubMed Central · Cited by 11

Isolation and Identification of a Rare Spike Gene Double-Deletion SARS-CoV-2 Variant From the Patient With High Cycle Threshold Value

Liu, L., Tsai, J., Chen, C., Lin, P., Tsai, C., Tsai, Y., Hsu, M., Chuang, W., Chang, J., Hwang, S., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.822633 · Cited by 11

A Perspective on COVID-19 Management

Pavelić, K., Pavelić, S. K., Brix, B., & Goswami, N. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081586 · Cited by 12

SARS-CoV-2 spike D614G variant exhibits highly efficient replication and transmission in hamstersPreprint

Mok, B. W.-Y., Cremin, C. J., Lau, S.-Y., Deng, S., Chen, P., Zhang, J., Lee, A. C.-Y., Liu, H., Liu, S., Ng, T. T.-L., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.28.271635 · Cited by 11

Sentinel cells enable genetic detection of SARS-CoV-2 Spike proteinPreprint

Weinberg, Z. Y., Hilburger, C. E., Kim, M. J., Cao, L., Khalid, M. M., Elmes, S., Diwanji, D. C., Hernandez, E., Lopez, J., Schaefer, K., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.20.440678 · Cited by 12

Rapid expansion of SARS-CoV-2 variants of concern is a result of adaptive epistasisPreprint

Garvin, M. R., Prates, E. T., Romero, J., Cliff, A., Gazolla, J. G. F. M., Pickholz, M., Pavicic, M., & Jacobson, D. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.03.454981 · Cited by 10

Highly potent dual-targeting angiotensin-converting enzyme 2 (ACE2) and Neuropilin-1 (NRP1) peptides: A promising broad-spectrum therapeutic strategy against SARS-CoV-2 infection

Mei, S., Zou, Y., Jiang, S., Lü, X., Wang, Y., Han, J. D. J., Yang, P., Niu, M., Li, J., Yuan, K., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115908 · Cited by 10

Vero cell-adapted SARS-CoV-2 strain shows increased viral growth through furin-mediated efficient spike cleavage

Minami, S., Kotaki, T., Sakai, Y., Okamura, S., Torii, S., Ono, C., Motooka, D., Hamajima, R., Nouda, R., Nurdin, J. A., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.02859-23 · Cited by 10

Characterizing neuroinvasion and neuropathology of SARS-CoV-2 by using AC70 human ACE2 transgenic mice

Hsu, J. C., Saenkham, P., Huang, P., Octaviani, C. P., Drelich, A. K., Peng, B., & Tseng, C.-T. K. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1455462 · Cited by 10

Unraveling the SARS-CoV-2 spike protein long-term effect on neuro-PASC

Menezes, F., Palmeira, J. D. F., Oliveira, J. D. S., Argañaraz, G. A., Soares, C. R. J., Nóbrega, O. D. T., Ribeiro, B. M., & Argañaraz, E. R. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1481963 · Cited by 10

Structural basis of TMPRSS11D specificity and autocleavage activation

Fraser, B. J., Wilson, R. P., Ferková, S., Ilyassov, O., Lac, J., Dong, A., Li, Y.-Y., Seitova, A., Li, Y., Hejazi, Z., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59677-3 · Cited by 11

Effect of the S2’ site cleavage on SARS-CoV-2 spike

Shi, W. K., Jonaid, G. M., Kibria, M. G., Allen, J., Peng, H., Rits‐Volloch, S., Zhu, H., Wang, S., Walsh, R. M., Lu, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66693-w · Cited by 11

Techniques assisting peptide vaccine and peptidomimetic design. Sidechain exposure in the SARS-CoV-2 spike glycoprotein

Robson, B. (2020) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2020.104124 · Cited by 10

Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion

Papa, G., Mallery, D. L., Albecka, A., Welch, L. G., Cattin‐Ortolá, J., Lupták, J., Paul, D., McMahon, H. T., Goodfellow, I., Carter, A. P., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009246 · Cited by 321

The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets

Peacock, T. P., Goldhill, D. H., Zhou, J., Baillon, L., Frise, R., Swann, O. C., Kugathasan, R., Penn, R., Brown, J. C., Sanchez-David, R. Y., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-021-00908-w · Cited by 802

The furin cleavage site of SARS-CoV-2 spike protein is a key determinant for transmission due to enhanced replication in airway cellsPreprint

Peacock, T. P., Goldhill, D. H., Zhou, J., Baillon, L., Frise, R., Swann, O. C., Kugathasan, R., Penn, R., Brown, J. C., Sanchez-David, R. Y., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.30.318311 · Cited by 88

Why All the Fury over Furin?

Osman, E. E. A., Rehemtulla, A., & Neamati, N. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00518 · Cited by 54

A robust reporting system for measurement of SARS-CoV-2 spike fusion efficiency

Huang, C., Yang, Y., Yang, P., Wang, F., Li, X., Song, X., Wang, Y., Yu, C., Wang, X., & Wang, S. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01037-4 · Cited by 6